Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/ccr3.3487 http://scihub22266oqcxt.onion/10.1002/ccr3.3487 33489151!7813092!33489151     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Case+Rep 2021 ; 9 (1): 148-152 Nephropedia Template TP {{tp|p=33489151|t=2021. Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19 |pdf=|usr=}}{{33489151}} gab.com Text Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19 JO: Clin Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=33489151 #FOAvip The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life-threatening bleeding and mortality. Twit Text FOAVip Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19 ????Clin Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=33489151 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33489151 #FOAvip English Wikipedia <ref>{{Cite pmid|33489151}}</ref> Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19 #MMPMID33489151 Khatib MY; Shaik KS; Ahmed AA; Alwraidat MA; Mohamed AS; Abou Kamar MR; Sharaf Eldean MZ; Aldaraiseh BK; Nashwan AJ Clin Case Rep 2021[Jan]; 9 (1): 148-152 PMID33489151show ga The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life-threatening bleeding and mortality. äTocilizumab-induced cytomegalovirus colitis in a patient with COVID-19(epmc).pdf DeepDyve Pubget Overpricing